by Kara Bettis | http://newbostonpost.com
BOSTON – When Carl and Julie Stone discovered four years ago that their third child, Josiah, would be born with trisomy 21, or Down syndrome, they didn’t blink.
“It didn’t frighten us, it didn’t scare us, it didn’t make us sad,” Stone said. “We simply wanted to spend the last 20 weeks of the pregnancy doing everything we could to give this child every possibility to succeed.”
The Carver resident’s story is not unusual. But it isn’t common, either. Many expecting families who discover the child might be born with trisomy 21, a form of Down syndrome that comes from having an extra chromosome, don’t know where to turn, or what kind of life to expect for their baby.
by Nicholas Jackson | drugtargetreview.com
Plans for the world’s first clinical trial for a vaccine targeting Alzheimer’s disease-like characteristics in those with Down’s syndrome have been announced. The study will test AC Immune’s vaccine ACI-24 and is being conducted in collaboration with the University of California, San Diego (UC San Diego) Down’s Syndrome Research and Treatment Center. Funding is provided by a significant grant from the US National Institutes of Health (NIH) and an additional grant from the LuMind Research Down’s Syndrome Foundation. This is the first public/private collaboration for a clinical trial in the field of Down’s syndrome.
By SocialSecurity.gov Official Social Security Website
We recently released new fact sheets and a national issue paper on the Social Security Disability Insurance (SSDI) program. The SSDI program provides benefits to millions of workers and their families in every community across America. These State fact sheets contain statistics on the number of people who receive benefits and the average payment amounts. The national issue paper describes the five principles Congress used as a basis for establishing the SSDI program almost 60 years ago.